Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
DNDi Drugs for Neglected Diseases initiative
DNDi Drugs for Neglected Diseases initiative
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Bayer and DNDi to develop oral treatment for human river blindness
German healthcare giant will provide active ingredient emodepside which shows potential as a macrofilaricidal drug
Research & Development
Old drug shows new promise to treat leishmaniasis
University of Dundee scientists study fexinidazole
Research & Development
Drug companies join forces to end neglected tropical diseases
Will expand drug donation programmes and provide US$785m to support r&d efforts
Research & Development
Sanofi and DNDi sign research collaboration deal
To generate new drugs for Neglected Tropical Diseases
Regulatory
Pfizer and DNDi enter tropical disease partnership
To support the development of improved treatments for neglected African diseases
Sustainability
Consortium to develop drugs for neglected tropical diseases
<p>A consortium has been formed to develop drugs for the treatment of African sleeping sickness and Leishmaniasis, which affect millions of people worldwide. </p>
Research & Development
Merck & Co and DNDi collaborate to find treatments for world's most neglected tropical diseases
To develop improved treatments for NTDs such as visceral leishmaniasis and Chagas disease
Subscribe now